Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Bone and Mineral Metabolism
Metadata
Title
Assessment of bone quality using micro-computed tomography (micro-CT) and synchrotron micro-CT
Author
Masako Ito
Publication date
01-01-2005
Publisher
Springer-Verlag
Published in
Journal of Bone and Mineral Metabolism / Issue Special Issue 1/2005
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/BF03026335

Other articles of this Special Issue 1/2005

Journal of Bone and Mineral Metabolism 1/2005 Go to the issue

Invited paper

Epidemiology of osteoporosis in Japan

Original article

Raloxifene and teriparatide (hPTH 1-34) have complementary effects on the osteopenic skeleton of ovariectomized rats

Invited paper

Biopolymer-based delivery systems for advanced imaging and skeletal tissue-specific therapeutics

Original Article

THe effects of suppressed bone remodeling by bisphosphonates on microdamage accumulation and degree of mineralization in the cortical bone of dog rib

OriginalPaper

Absorptiometric assessment of muscle-bone relationships in humans: reference, validation, and application studies

OriginalPaper

Novel experimental effects on bone material properties and the pre- and postyield behavior of bones may be independent of bone mineralization

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits